Microvessel density and outcome of adjuvant treatment of breast cancer patients

被引：0
|
作者：
Voest, EE
Blijham, GH
机构：
来源：
CANCER JOURNAL FROM SCIENTIFIC AMERICAN | 1997年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [31] Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
    Kristi Krüger
    Laxmi Silwal-Pandit
    Elisabeth Wik
    Oddbjørn Straume
    Ingunn M. Stefansson
    Elin Borgen
    Øystein Garred
    Bjørn Naume
    Olav Engebraaten
    Lars A. Akslen
    Scientific Reports, 11
  • [32] EFFECT OF ADJUVANT THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Tsaaareli, M.
    Giorgadze, E.
    Khachidze, N.
    Sharilcadze, N.
    Dolidze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S268 - S269
  • [33] Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients
    Kim, Minsung
    Kim, Hanna
    Ahn, Sei Hyun
    Tabatabaie, Vafa
    Choi, Sung Wook
    Sohn, Guiyun
    Lee, Sae Byul
    Ko, Beom Seok
    Chung, Il Yong
    Kim, Jisun
    Lee, Jong Won
    Son, Byung Ho
    Kim, Hee Jeong
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 657 - 663
  • [34] Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients
    Minsung Kim
    Hanna Kim
    Sei Hyun Ahn
    Vafa Tabatabaie
    Sung Wook Choi
    Guiyun Sohn
    Sae Byul Lee
    Beom Seok Ko
    Il Yong Chung
    Jisun Kim
    Jong Won Lee
    Byung Ho Son
    Hee Jeong Kim
    Breast Cancer Research and Treatment, 2020, 180 : 657 - 663
  • [35] BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy
    Beata Biesaga
    Joanna Niemiec
    Marek Ziobro
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 2009 - 2019
  • [36] Proliferation rate, microvessel density, expressions of HER-2, hormone receptors and P53 protein as predictors of tumour response to adjuvant anthracycline treatment in breast cancer patients
    Biesaga, B.
    Niemiec, J.
    Ziobro, Z.
    Wysocka, J.
    Kruczak, A.
    EJC SUPPLEMENTS, 2008, 6 (07): : 183 - 184
  • [37] Outcome of Treatment After Locoregional Radiation, Neoadjuvant and Adjuvant Chemotherapy for Breast Cancer
    Anie, H. N. Ayettey
    Yarney, J.
    Sanuade, O.
    Awasthi, S.
    Ndanu, T. Akuetteh
    Parekh, A.
    Aidoo, C. A.
    Dadzie, M. A.
    Vanderpuye, V.
    Yamoah, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E418 - E418
  • [38] Breast cancer pharmacogenetics: Case control study on TAM adjuvant treatment outcome
    Yadav, S. S.
    Chauhan, V.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer - Response
    Berry, DA
    Budman, DR
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (03) : 286 - 287
  • [40] Patients with triple negative breast cancer: Is there an optimal adjuvant treatment?
    Burstein, Harold J.
    BREAST, 2013, 22 : S147 - S148
12345